Organization · Venture Capital
Scientific Health Development
Scientific Health Development (SHD) is a venture capital firm based in Dallas, Texas, specializing in early-stage investments in medical technology companies that address unmet clinical needs.
Overview
What Scientific Health Development does
What Scientific Health Development is
Scientific Health Development (SHD) is a venture capital firm based in Dallas, Texas, specializing in early-stage investments in medical technology companies that address unmet clinical needs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2006
- Approximate age
- About 20 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find Scientific Health Development elsewhere
Open the official website or a supported primary organization account.
Capability profile
Scientific Health Development as a funder
Investment thesis
Scientific Health Development invests in early-stage medical technology companies that address unmet clinical needs, focusing on easily adoptable technologies that improve patient outcomes while minimizing economic burdens.
Focus narrative
SHD focuses on early-stage investments in innovative medical technologies that require smaller amounts of funding and have attainable, near-term value inflection points leading to potential exits. The firm seeks companies that develop easily adoptable technologies aimed at improving patient outcomes while minimizing economic burdens.
Value beyond capital
SHD adds value to its portfolio companies by providing strategic guidance, leveraging its extensive network in the medtech industry, and facilitating access to co-investors such as InCube Ventures and Boston Scientific. The firm focuses on helping companies achieve their near-term value inflection points, enhancing their potential for successful exits.
Terms and economics
- Typical check
- $10,000,000–$50,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Notable portfolio companies include: Podimetrics: Focuses on early detection of diabetic foot ulcers. Koya Medical: Develops smart compression technology for lymphedema. Mindera Health: Specializes in non-invasive molecular skin testing. Procyrion: Offers a minimally invasive cardiac support device. Liberate Medical: Provides non-invasive respiratory stimulation. Empirical Spine: Develops motion-preserving spinal implant alternatives to fusion. Cooler Heads: Provides scalp cooling to avoid chemotherapy-induced hair loss. Arctx Medical: Focuses on minimally invasive devices for localized cooling. AlgoMedica: Works on low-dose radiation technology for medical imaging. CereVu: Develops real-time objective pain management solutions.
Common questions
What to know about Scientific Health Development
Upseed classifies Scientific Health Development under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.